Influence of Intensive versus Conventional Glucose Control on Microvascular and Macrovascular Complications in Type 1 and 2 Diabetes Mellitus

被引：0
|
作者：
Taina K. Mattila
Anthonius de Boer
机构：
[1] Utrecht University,Department of Pharmaceutical Sciences, Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS)
来源：
Drugs | 2010年 / 70卷
关键词：
Metformin; Rosiglitazone; Pioglitazone; Microvascular Complication; Severe Hypoglycaemia;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
In type 1 and 2 diabetes mellitus patients, hyperglycaemia is independently related to the development of microvascular and macrovascular complications. Glycaemic targets and the benefits of intensive versus conventional glucose control are under debate. The purpose of this review is to provide an overview of the randomized controlled trials and meta-analyses comparing the effects of intensive versus conventional glucose control on microvascular and macrovascular complications in type 1 and 2 diabetes.
引用
收藏
页码：2229 / 2245
页数：16
相关论文
共 50 条
  • [21] Does blood glucose control prevent macrovascular complications of type 2 diabetes?
    Charbonnel, Bernard
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2018, 202 (5-6): : 897 - 906
  • [22] Microvascular Complications of Type 2 Diabetes Mellitus
    Faselis, Charles
    Katsimardou, Alexandra
    Imprialos, Konstantinos
    Deligkaris, Pavlos
    Kallistratos, Manolis
    Dimitriadis, Kiriakos
    CURRENT VASCULAR PHARMACOLOGY, 2020, 18 (02) : 117 - 124
  • [23] Subclinical macrovascular complications in patients with Type 1 diabetes mellitus
    Vastagh, I.
    Horvath, T.
    Nagy, G.
    Varga, T.
    Juhasz, E.
    Juhasz, V.
    Kollai, M.
    Bereczki, D.
    Somogyi, A.
    CEREBROVASCULAR DISEASES, 2013, 35 : 434 - 434
  • [24] Genetic susceptibility to macrovascular complications of type 2 diabetes mellitus
    Barakat, K
    Hitman, GA
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 15 (03) : 359 - 370
  • [25] Serum asymmetric dimethylarginine and arginine levels predict microvascular and macrovascular complications in type 2 diabetes mellitus
    Ganz, Tali
    Wainstein, Julio
    Gilad, Suzan
    Limor, Rona
    Boaz, Mona
    Stern, Naftali
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2017, 33 (02)
  • [26] Skin autofluorescence and the presence of microvascular and macrovascular complications in patients with type 2 diabetes mellitus: a multicenter study
    Lefrandt, J. D.
    Noordzij, M. J.
    Brouwer, T.
    Jager, J.
    Cabezas, M. Castro
    Oomen, P. H. N.
    Mulder, D. J.
    Smit, A. J.
    DIABETOLOGIA, 2011, 54 : S510 - S510
  • [27] Retinal Vascular Fractals and Microvascular and Macrovascular Complications in Type 1 Diabetes
    Grauslund, Jakob
    Green, Anders
    Kawasaki, Ryo
    Hodgson, Lauren
    Sjolie, Anne Katrin
    Wong, Tien Y.
    OPHTHALMOLOGY, 2010, 117 (07) : 1400 - 1405
  • [28] Effects of islet transplantation on microvascular and macrovascular complications in type 1 diabetes
    Reid, Laura
    Baxter, Faye
    Forbes, Shareen
    DIABETIC MEDICINE, 2021, 38 (07)
  • [29] Accumulation of advanced glycation end products is associated with macrovascular events and glycaemic control with microvascular complications in Type 2 diabetes mellitus
    Yozgatli, K.
    Lefrandt, J. D.
    Noordzij, M. J.
    Oomen, P. H. N.
    Brouwer, T.
    Jager, J.
    Cabezas, M. Castro
    Smit, A. J.
    DIABETIC MEDICINE, 2018, 35 (09) : 1242 - 1248
  • [30] Macrovascular and microvascular type 2 diabetes complications are interrelated in a mouse model
    Cifuentes-Mendiola, S. E.
    Solis-Suarez, D. L.
    Martinez-Davalos, A.
    Garcia-Hernandez, A. L.
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2023, 37 (05)
12345